108 related articles for article (PubMed ID: 8182700)
1. Conformational analysis of the prototype nonclassical cannabinoid CP-47,497, using 2D NMR and computer molecular modeling.
Xie XQ; Yang DP; Melvin LS; Makriyannis A
J Med Chem; 1994 May; 37(10):1418-26. PubMed ID: 8182700
[TBL] [Abstract][Full Text] [Related]
2. The conformational properties of the highly selective cannabinoid receptor ligand CP-55,940.
Xie XQ; Melvin LS; Makriyannis A
J Biol Chem; 1996 May; 271(18):10640-7. PubMed ID: 8631869
[TBL] [Abstract][Full Text] [Related]
3. Conformational studies on a diastereoisomeric pair of tricyclic nonclassical cannabinoids by NMR spectroscopy and computer molecular modeling.
Xie XQ; Pavlopoulos S; DiMeglio CM; Makriyannis A
J Med Chem; 1998 Jan; 41(2):167-74. PubMed ID: 9457240
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach.
Reggio PH; Panu AM; Miles S
J Med Chem; 1993 Jun; 36(12):1761-71. PubMed ID: 8510104
[TBL] [Abstract][Full Text] [Related]
5. Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids.
Xie XQ; Eissenstat M; Makriyannis A
Life Sci; 1995; 56(23-24):1963-70. PubMed ID: 7776820
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships defining the ACD-tricyclic cannabinoids: cannabinoid receptor binding and analgesic activity.
Melvin LS; Milne GM; Johnson MR; Wilken GH; Howlett AC
Drug Des Discov; 1995 Nov; 13(2):155-66. PubMed ID: 8872458
[TBL] [Abstract][Full Text] [Related]
7. Location, structure, and dynamics of the synthetic cannabinoid ligand CP-55,940 in lipid bilayers.
Kimura T; Cheng K; Rice KC; Gawrisch K
Biophys J; 2009 Jun; 96(12):4916-24. PubMed ID: 19527650
[TBL] [Abstract][Full Text] [Related]
8. Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptors.
Durdagi S; Reis H; Papadopoulos MG; Mavromoustakos T
Bioorg Med Chem; 2008 Aug; 16(15):7377-87. PubMed ID: 18595717
[TBL] [Abstract][Full Text] [Related]
9. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
10. Structure elucidation and conformational properties of synthetic cannabinoids (-)-2-(6a,7,10,10a-tetrahydro-6,6,9-trimethyl-1-hydroxy-6H-dibe nzo [b,d]pyranyl)-2-hexyl-1,3-dithiolane and its methylated analog.
Mavromoustakos T; Theodoropoulou E; Zervou M; Kourouli T; Papahatjis D
J Pharm Biomed Anal; 1999 Jan; 18(6):947-56. PubMed ID: 9925329
[TBL] [Abstract][Full Text] [Related]
11. Classical/non-classical cannabinoid hybrids; stereochemical requirements for the southern hydroxyalkyl chain.
Tius MA; Hill WA; Zou XL; Busch-Petersen J; Kawakami JK; Fernandez-Garcia MC; Drake DJ; Abadji V; Makriyannis A
Life Sci; 1995; 56(23-24):2007-12. PubMed ID: 7776825
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.
Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK
J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515
[TBL] [Abstract][Full Text] [Related]
13. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling.
Bélec L; Blankenship JW; Lubell WD
J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022
[TBL] [Abstract][Full Text] [Related]
14. High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2.
Xie XQ; Han XW; Chen JZ; Eissenstat M; Makriyannis A
J Med Chem; 1999 Oct; 42(20):4021-7. PubMed ID: 10514272
[TBL] [Abstract][Full Text] [Related]
15. Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.
Busch-Petersen J; Hill WA; Fan P; Khanolkar A; Xie XQ; Tius MA; Makriyannis A
J Med Chem; 1996 Sep; 39(19):3790-6. PubMed ID: 8809166
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
Reggio PH; Seltzman HH; Compton DR; Prescott WR; Martin BR
Mol Pharmacol; 1990 Dec; 38(6):854-62. PubMed ID: 2174506
[TBL] [Abstract][Full Text] [Related]
17. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
[TBL] [Abstract][Full Text] [Related]
18. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
[TBL] [Abstract][Full Text] [Related]
19. Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists.
Wiley JL; Beletskaya ID; Ng EW; Dai Z; Crocker PJ; Mahadevan A; Razdan RK; Martin BR
J Pharmacol Exp Ther; 2002 May; 301(2):679-89. PubMed ID: 11961073
[TBL] [Abstract][Full Text] [Related]
20. A Study about Regioisomeric Hydroquinones with Multiple Intramolecular Hydrogen Bonding.
Martínez-Cifuentes M; Cardona W; Saitz C; Weiss-López B; Araya-Maturana R
Molecules; 2017 Apr; 22(4):. PubMed ID: 28387716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
